An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects, scientists reported on Wednesday.» Read More
Genetics startup 23andMe said it is one step closer to resuming sales of its full-fledged health product.
Wealthy Americans worry about the impact of high health care costs in old age, and see it as one of the biggest risks to their financial security.
People who had their old health care plans canceled aren't necessarily paying higher premiums under Obamacare, according to a Kaiser Family Foundation survey.
Prosecutors have issued subpoenas in an investigation into whether congressional staff tipped stock traders to a change in health-care policy. The WSJ reports.
People who receive subsidies and opted for the second-cheapest group HealthCare.gov plans now pay just $69 per month on average in premiums.
ZocDoc is the new king of New York start-ups.
Mehmet Oz acknowledged that his backing of so called miracle weight loss products has caused trouble to for the FTC, Consumerist reports.
Electronic cigarettes, promoted as a healthier alternative to tobacco, are getting powerful new backers: big tobacco firms. NYT reports.
Valeant said it plans to launch an exchange offer to Allergan shareholders this week, soliciting proxies to call for a meeting to discuss its offer.
The Food and Drug Administration is preparing voluntary guidelines for the food industry to lower sodium levels to address health concerns.
As the global population ages, some see investment opportunities in somewhat ghoulish bets the rates of cancer and other illnesses will rise.
The United States health-care system has again come in last in a comparison of other first-world countries, despite vastly outspending those nations.
Medtronic's $43 billion Covidien deal may signal future medical-device company mergers.
WebMD will launch Healthy Target, a service that collects data from wearables to offer up personalized health content and tips.
Some Americans who've enrolled in an Obamacare exchange plan with a government subsidy could find themselves on the hook to Uncle Sam next spring.
In-network health providers charge insured patients a wide range of prices for the same services in different cities—and even in the same city.
Medtronic is buying Covidien in a $42.9 billion agreement that could increase concerns about the rush of U.S. companies striking deals to cut their tax bills.
Many of the world's biggest drugmakers will gather starting Friday in San Francisco for the American Diabetes Association's annual meeting. Here's what investors need to know.
This month, the full moon falls on Friday the 13th. Freaky? Nah, probably not.
Data released shows weaker health care spending in the US.
Get the best of CNBC in your inbox